Indian Council of Medical Research’s (ICMR) approval for the country’s first self-use rapid antigen test for covid-19, CoviSelf. The approval followed an advisory by the apex biomedical research agency late Wednesday, allowing the use of self-testing kits even as it cautioned against its indiscriminate use. The test can be purchased for ₹250 without a prescription from local pharmacies and online channel partners, the Pune-based company said in a statement. Testing will be monitored using Mylab’s mobile phone application, through which users are advised to click a picture of the test strip after completing the procedure. Mint explains the modalities of the new testing kit and what it could mean in the battle against the pandemic.